Moderna, Inc. — Director's Dealing 2020

Dec 1, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2020-11-30

Reporting Person: Zaks Tal Zvi (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-30	Common Stock	M	5000	$12.21	Acquired	5000	Direct
2020-11-30	Common Stock	M	5000	$14.22	Acquired	10000	Direct
2020-11-30	Common Stock	M	10000	$19.15	Acquired	20000	Direct
2020-11-30	Common Stock	S	800	$142.43	Disposed	19200	Direct
2020-11-30	Common Stock	S	600	$144.09	Disposed	18600	Direct
2020-11-30	Common Stock	S	1660	$145.25	Disposed	16940	Direct
2020-11-30	Common Stock	S	2108	$146.12	Disposed	14832	Direct
2020-11-30	Common Stock	S	3335	$147.22	Disposed	11497	Direct
2020-11-30	Common Stock	S	5893	$148.35	Disposed	5604	Direct
2020-11-30	Common Stock	S	4100	$149.38	Disposed	1504	Direct
2020-11-30	Common Stock	S	700	$150.09	Disposed	804	Direct
2020-11-30	Common Stock	S	100	$151.00	Disposed	704	Direct
2020-11-30	Common Stock	S	312	$152.74	Disposed	392	Direct
2020-11-30	Common Stock	S	392	$153.50	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-30	Stock Option (Right to Buy)	$12.21	M	5000	Disposed	2027-02-23	Common Stock (5000)	Direct
2020-11-30	Stock Option (Right to Buy)	$14.22	M	5000	Disposed	2028-02-28	Common Stock (5000)	Direct
2020-11-30	Stock Option (Right to Buy)	$19.15	M	10000	Disposed	2026-08-10	Common Stock (10000)	Direct

Footnotes

F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $142.21 to $142.86. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $143.63 to $144.42. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $144.65 to $145.55. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $145.67 to $146.67. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $146.70 to $147.67. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F7: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $147.85 to $148.85. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F8: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $148.93 to $149.93. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F9: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $149.94 to $150.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F10: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $152.35 to $153.32. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F11: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $153.40 to $153.65. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F12: 25% of this option vested and became exercisable on February 22, 2018 with the remainder vesting in 12 equal quarterly installments thereafter.

F13: 25% of this option vested and became exercisable on February 27, 2019 with the remainder vesting in 12 equal quarterly installments thereafter.

F14: This option is fully vested and exercisable.